MP40-14 OVERALL SURVIVAL AMONG ELDERLY PATIENTS WITH LOCALIZED UPPER TRACT UROTHELIAL CARCINOMA RECEIVING OBSERVATION VERSUS DEFINITIVE TREATMENT

Abstract

You have accessJournal of UrologyCME1 May 2022MP40-14 OVERALL SURVIVAL AMONG ELDERLY PATIENTS WITH LOCALIZED UPPER TRACT UROTHELIAL CARCINOMA RECEIVING OBSERVATION VERSUS DEFINITIVE TREATMENT Syed Rahman, Jamil Syed, Soum Lokeshwar, Benjamin Press, Thomas Monaghan, and Michael Leapman Syed RahmanSyed Rahman More articles by this author , Jamil SyedJamil Syed More articles by this author , Soum LokeshwarSoum Lokeshwar More articles by this author , Benjamin PressBenjamin Press More articles by this author , Thomas MonaghanThomas Monaghan More articles by this author , and Michael LeapmanMichael Leapman More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002600.14AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Treatment decisions regarding elderly patients with upper tract urothelial carcinoma (UTUC) can be challenging given competing risks associated with age and comorbidities. Herein we assess survival outcomes among patients 80+ years diagnosed with clinically localized UTUC managed with definitive surgery versus expectant management. METHODS: We utilized the Surveillance, Epidemiology, and End Results (SEER) database (2004-2015) to identify individuals 80 years of age diagnosed with localized (cT1-4N0M0), kidney/renal pelvis and ureteral urothelial carcinoma. Survival analysis included Kaplan-Meier analysis and multivariable Cox proportional hazard analysis with adjustment of demographic and clinical variables. RESULTS: We identified 521 individuals with localized UTUC 80+ years of age. 159 patients (29.1%) did not receive definitive surgery and 362 patients (70.9%) received surgery. Patients managed expectantly were older (57.9% vs. 39.0% >85 years, p <0.01) and more commonly had high grade tumors (47.2% vs. 37.1%, p <0.05). Median OS was significantly higher in the surgical cohort (45.3 months vs 18.5 months, p <0.001). The 3-year disease specific survival (DSS) was lower in the non-surgical cohort, (39.6% months vs. 53.0%, p <0.001). Overall, surgery was associated with improved OS compared to non-surgical management in patients >80 years of age (HR 0.53 [0.42-0.69, p <0.001). Age >85 years (HR 1.63 [1.34-1.93], p <0.001) and high grade (HR 1.22 [1.06-1.31] p <0.05). CONCLUSIONS: Among patients ≥80 years with localized UTUC, initial definitive surgery was associated with improved OS, which may reflect candidate selection for definitive treatment. These findings highlight the need for improved decision support about definitive treatment for older patients with genitourinary malignancies. Source of Funding: None © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e680 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Syed Rahman More articles by this author Jamil Syed More articles by this author Soum Lokeshwar More articles by this author Benjamin Press More articles by this author Thomas Monaghan More articles by this author Michael Leapman More articles by this author Expand All Advertisement PDF DownloadLoading ...